Medibio Ltd
ASX:MEB
Medibio Ltd
ASX:MEB
Price:
0.02
AUD
Market Closed
Market Cap:
AU$122m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medibio Ltd
ASX:MEB
|
AU |
|
K
|
KonaTel Inc
OTC:KTEL
|
US |
Balance Sheet
Balance Sheet Decomposition
Medibio Ltd
Medibio Ltd
Balance Sheet Decomposition is not available for
Medibio Ltd
Medibio Ltd
Balance Sheet
Medibio Ltd
Medibio Ltd
Currency: AUD
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
5
|
6
|
1
|
1
|
2
|
1
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
|
| Cash Equivalents |
0
|
1
|
1
|
5
|
6
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
4
|
7
|
8
|
2
|
1
|
3
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
14
|
14
|
12
|
11
|
12
|
13
|
15
|
7
|
8
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
15
+201%
|
18
+18%
|
19
+7%
|
19
-1%
|
13
-30%
|
14
+5%
|
17
+24%
|
8
-51%
|
8
-5%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
2
|
6
|
6
|
4
|
2
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
3
|
6
|
6
|
5
|
5
|
1
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
6
+161%
|
9
+55%
|
6
-37%
|
5
-14%
|
5
-7%
|
1
-70%
|
1
-31%
|
1
+43%
|
2
+27%
|
|
| Equity | |||||||||||
| Common Stock |
37
|
51
|
56
|
69
|
84
|
84
|
92
|
96
|
99
|
102
|
|
| Retained Earnings |
35
|
42
|
47
|
56
|
70
|
76
|
79
|
80
|
92
|
96
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
9
+236%
|
8
-7%
|
13
+57%
|
14
+5%
|
9
-38%
|
13
+47%
|
16
+30%
|
7
-57%
|
6
-11%
|
|
| Total Liabilities & Equity |
5
N/A
|
15
+201%
|
18
+18%
|
19
+7%
|
19
-1%
|
13
-30%
|
14
+5%
|
17
+24%
|
8
-51%
|
8
-5%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
34
|
99
|
116
|
164
|
223
|
256
|
1 127
|
1 795
|
2 756
|
4 548
|
|
Switch to:
Switch to:
See Also
Discover More
